期刊文献+

雷珠单抗眼内注射辅助激光治疗用于糖尿病视网膜病变患者治疗中的效果评价 被引量:2

Effect Evaluation of Intraocular Injection of Ranibizumab for Assisted Laser Therapy in the Treatment of DR Patients
下载PDF
导出
摘要 目的应用雷珠单抗眼内注射辅助激光治疗糖尿病视网膜病变(DR)Ⅲ期及以上伴有黄斑水肿患者,评估对患者视网膜病变的改善作用。方法选择灌南县第一人民医院眼科2019年1月—2021年2月DR患者90例,随机分为两组,每组45例患者,90只眼。对照组进行激光治疗,研究组在激光治疗前给予雷珠单抗眼内注射辅助治疗。评估两组临床疗效、视力水平、视觉功能、黄斑区视网膜厚度、视网膜出血及渗出再发生率。结果研究组患者总有效率为94.44%(85/90),高于对照组84.44%(76/90),差异有统计学意义(P<0.05);研究组治疗后视力与对照组对比,差异无统计学意义(P>0.05),研究组治疗后视觉功能评分、黄斑区视网膜厚度、视网膜出血及渗出再发生率分别为(38.14±1.48)分、(264.02±22.57)μm、11.11%,均低于对照组,差异有统计学意义(P<0.05)。结论应用雷珠单抗眼内注射辅助激光治疗DR患者,患者视网膜病变改善显著。 Objective Intraocular injection of ranibizumab assisted laser treatment of diabetic retinopathy(DR) stage Ⅲ and above patients with macular edema, to evaluate the improvement of retinopathy in patients. Methods A total of 90 DR patients from the department of ophthalmology of the First People’s Hospital of Guannan County from January 2019 to February 2021 were selected and randomly divided into two groups, with 90 eyes of 45 patients in each group. The control group received laser therapy, and the study group received intraocular injection of ranibizumab as adjuvant therapy before laser therapy. Evaluated the clinical efficacy, visual acuity level, visual function, macular retinal thickness, retinal hemorrhage and recurrence rate of exudation of the two groups. Results The total effective rate of patients in the study group was 94.44%(85/90), which was higher than the control group84.44%(76/90), the difference was statistically significant(P<0.05). There was no statistically significant difference in visual acuity between the study group and the control group after treatment( P >0.05). The results of visual function score, macular retinal thickness and incidence of retinal hemorrhage in the study group after treatment were(38.14±1.48) points,(264.02±22.57) μm and 11.11%, lower than control group, the difference was statistically significant(P<0.05). Conclusion Ranibizumab intraocular injection assisted laser treatment of patients with DR, the retinopathy of patients improved significantly.
作者 吕夏微 LYU Xiawei(Department of Ophthalmology,the First People's Hospital of Guannan County,Lianyungang,Jiangsu Province,222599 China)
出处 《糖尿病新世界》 2022年第11期176-179,共4页 Diabetes New World Magazine
关键词 雷珠单抗 激光治疗 糖尿病视网膜病变 糖尿病性黄斑水肿 视觉功能 Ranibizumab Laser treatment Diabetic retinopathy Visual function
  • 相关文献

参考文献18

二级参考文献155

共引文献405

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部